USPTO serial 79262054
INCYTON
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jul 7, 2020
- Examiner
- WINTER, MELISSA S
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with INCYTON?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $748*
Plus Government fees of $850
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | scientific apparatus and instruments, namely, physiometabolic cell analyzer and screener; photoelectric sensors; optical readers; laboratory robots; diagnostic apparatus for the detection of pathogens for laboratory or research use, not for medical purposes; downloadable bioinformatics software for analyzing experimental and cellular physiological data; optical biochip sensors; biochips for research or scientific purposes; oxygen sensors not for medical use, namely, optical oxygen sensors for high precision measurement in life science; optical apparatus and instruments, namely, optical imaging apparatus not for medical use; scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking, life-saving and teaching apparatus and instruments, namely, multiparametric cellular analysis and monitoring apparatus, optical sensor reading apparatus; apparatus and instruments for microscopy, namely, microscopes; measuring instruments, namely, scientific instrumentation for measuring physiological parameters of cells; laboratory apparatus and instruments, namely, apparatus for manipulating and monitoring living cells; measurement apparatus in the nature of temperature, dissolved oxygen, pH, bioimpedance, relative humidity and gas composition of the atmosphere sensors other than for medical use; monitoring apparatus, namely, optical pH and dissolved oxygen monitors and electrical bioimpedance monitors, other than for medical use; laboratory incubators; incubators for laboratory use; bioreactors for cell culture; disposable plastic bioreactors for cell culture; optical sensors; biological microscopes; microscopes; scientific apparatus, namely, microscopic imaging system not for medical use; apparatus for recording images; bioreactors for laboratory use; testing apparatus not for medical purposes, namely, apparatus for testing cells and cellular reactions in defined and controlled conditions; data processing equipment; data processing apparatus and computers; research laboratory analyzers for measuring, testing and analyzing blood and other bodily fluids | ACTIVE | — |
| 042 | Scientific investigations for medical purposes; scientific research for medical purposes; scientific research relating to cosmetics; scientific research relating to biology; scientific research in the field of pharmacy; preparation of biological samples for testing and analysis in research laboratories; preparation of biological samples for analysis in research laboratories; preparation of biological samples for research purposes; rental of software for computers; rental of laboratory apparatus and instruments; rental of computer software; rental of computer programs; medical research; laboratory research services relating to pharmaceuticals; laboratory research in the field of chemistry; laboratory research in the field of cosmetics; cosmetic research; research and development services in the field of microorganisms and cells; research and development services in the field of biotechnology; research and development services for the pharmaceutical industry; research in the field of pharmaceuticals; research in the field of biotechnology; research and development of vaccines and medicines; design and development of testing and analysis methods for scientific research; biotechnological research; scientific biological laboratory services; biological research and analysis; biological research services; biological research; biochemical research and analysis; biochemical research services; consultancy in the field of biology; consultancy in the field of biochemistry; bacteriological research and analysis; bacteriological research; laboratory analysis in the field of molecular biology; scientific research for medical purposes in the field of cancerous diseases; research in the field of chemistry and biology; research in the field of bacteriology; scientific and technological services, namely, scientific testing and analysis and related research and design services in the field of pharmaceuticals; scientific and technological services, namely, scientific testing and analysis and research and design relating thereto in the field of vaccines and medications; scientific and technological services, namely, scientific testing and analysis and research and development relating thereto in the field of bacteriology; technical writing, namely, preparation of technological research reports; rental of computer software and programs; pharmaceutical research services; pharmaceutical research and development services; medical research laboratory services; medical research services; laboratory research in the field of pharmaceuticals; research services in the field of proteins, antibodies, microorganisms and cells; research and development services in the field of antibodies; biological research laboratory services; scientific laboratory services; laboratory research in the field of bacteriology; research and development services in the field of bacteriology; laboratory analysis in the field of bacteriology; research and development in the field of biochemistry; research and development in the field of biotechnology; research and development in the field of microorganisms and cells; research and development of vaccines; research and development services in the field of cytology; research and development services in the field of immunology; research and development services in the field of gene expression systems; research and development services in the field of chemistry; research and development services in the field of antibody technology; research in the field of chemistry; biological and chemical research; chemical research and analysis; biological and chemical research services; chemical research and analysis services; biotechnology research; scientific research for medical purposes in the area of cancerous diseases; technical writing, namely, preparation of scientific reports; technical writing, namely, preparation of reports relating to scientific research; providing information relating to scientific research in the fields of biochemistry and biotechnology; laboratory pharmaceutical testing; laboratory chemical testing services; analytical laboratory services for testing pharmaceuticals; laboratory research and analysis relating to pharmaceuticals; conducting of chemical analyses; biological research and analysis services; scientific research services for medical purposes; medical and pharmacological research services; biochemical analysis; biochemical research; biochemical analysis services; provision of scientific information and data relating to medical and veterinary research and development; providing scientific information and data relating to medical and veterinary research and development; scientific advisory services relating to gene therapy research; consultancy relating to laboratory testing; consultancy in the field of pharmaceutical research; consultancy in the field of pharmacology; consultancy pertaining to pharmacology; consultancy relating to research and development in the field of therapeutic pharmaceuticals; consultancy relating to research in the field of pharmacogenetics; consultancy relating to pharmaceutical research and development; pharmaceutical research and development; research in the field of pharmacogenetics; consultancy in the field of biotechnology; providing technical advice in the field of scientific and industrial research; consultancy in the field of scientific research | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Dr. Helmut Herz
- Other trademarks owned by Dr. Helmut Herz
- Other trademarks owned by Incyton Biotech GmbH
- Other trademarks owned by INCYTON GmbH
- Other trademarks owned by INCYTON GmbH
- Other trademarks in Class 009
- Other trademarks in Class 042
- Similar marks named INCYTON
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Dec 11, 2025 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Nov 6, 2025 | CHLD | CHANGE OF OWNER RECEIVED FROM IB | — |
| Jul 7, 2025 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Nov 21, 2020 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Nov 3, 2020 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Nov 3, 2020 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Oct 7, 2020 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jul 7, 2020 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jun 26, 2020 | CHLD | CHANGE OF OWNER RECEIVED FROM IB | — |
| Apr 21, 2020 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Apr 21, 2020 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Apr 1, 2020 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Mar 19, 2020 | ALIE | ASSIGNED TO LIE | — |
| Mar 13, 2020 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 13, 2020 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Mar 13, 2020 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Mar 13, 2020 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Mar 13, 2020 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Feb 11, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 10, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 10, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 30, 2019 | RFNT | REFUSAL PROCESSED BY IB | — |
| Aug 14, 2019 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Aug 14, 2019 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jul 17, 2019 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jul 16, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 16, 2019 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jul 10, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 10, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 4, 2019 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |